Neural correlates of reward processing in schizophrenia — Relationship to apathy and depression
Introduction
The mesolimbic dopamine system is crucial for the processing of reward-related information and appears to be dysfunctional in patients with schizophrenia (Abi-Dargham et al., 2000). The importance of this system in the pathophysiology of schizophrenia has been highlighted in recent studies investigating the relationship between the neural processing of rewards and schizophrenic symptoms (Juckel et al., 2006b, Waltz et al., 2008).
More specifically, the “wanting” of a reward, which arises from its motivational incentive value (Berridge and Robinson, 1998), appears to be directly impaired in schizophrenia. Both unmedicated patients with schizophrenia and those treated with typical antipsychotics show reduced activation of the ventral striatum (VS) during reward anticipation (Juckel et al., 2006a, Kirsch et al., 2007, Schlagenhauf et al., 2008). Furthermore, a negative correlation has been found between VS activation and overall negative symptoms in unmedicated patients with schizophrenia (Juckel et al., 2006b).
Group differences in brain activation during the receipt of a reward (i.e., “liking”) have received less attention than differences arising during reward anticipation. One study compared patients treated with typical and atypical antipsychotics and found no differences during the processing of a rewarding outcome (Kirsch et al., 2007). In contrast, a further study demonstrated that higher delusional symptoms were associated with smaller medial-prefrontal-activation differences between successful and unsuccessful loss-avoidance in unmedicated patients with schizophrenia (Schlagenhauf et al., 2009).
The nature of the impairment in different stages of neural reward processing and the relationship between these stages and the negative symptoms observed in schizophrenia (e.g.: anhedonia, apathy) are thus subject to continued debate. Here, we propose a simple framework which integrates the heterogeneous findings on reward-processing impairments in schizophrenia by relating specific aspects of negative symptoms to different stages of reward processing and the corresponding structures of the dopaminergic reward system (Fig. 1).
Reward anticipation or the “wanting” of a reward has been associated with motivational processes which promote goal-directed behaviours that aim to achieve desired rewards (Schultz, 2002). Apathy or a loss of motivation, which leads to the reduction of goal-directed behaviours (Marin, 1991), may be specifically related to deficits at this stage of reward processing. Apathy is considered to be a common but treatment-resistant symptom (Buckley and Stahl, 2007) and has been conceptualised as a lack of responsiveness to stimuli and self-initiated action (Stuss et al., 2000). This symptom might therefore be a direct consequence of the diminished activation of the VS observed in patients with schizophrenia during anticipation (Fig. 1a).
The hedonic impact or the “liking” of a reward has been linked to activity in prefrontal areas and specifically to the medial orbitofrontal cortex (mOFC) (Kringelbach, 2005), whereas the VS codes positive prediction errors in response to unexpected rewards (Berns et al., 2001). Impaired neural processing during this stage of reward processing may be independent from motivational components given that hedonic impact has been found to be independent from anticipation effects (Gard et al., 2007, Kring and Neale, 1996). Anhedonia and depression represent common yet distinct symptoms of schizophrenia and are both negatively related to experiences of positive emotions in daily life (Horan et al., 2006, Pizzagalli et al., 2005, Siris, 2000). Both symptoms are additionally characterised by an altered reward circuitry (Holcomb and Rowland, 2007, Martin-Soelch, 2009). Consequently, blunted responses to rewarding outcomes may be related to these symptoms (Fig. 1b).
In the present study, we compared the neural activation of healthy controls and patients with schizophrenia treated with atypical neuroleptics during both reward anticipation and outcome. Our main goal was to relate specific symptoms of schizophrenia – notably apathy, anhedonia, and depression – to changes in neural activity during the different stages of reward processing.
Section snippets
Participants
We included 15 right-handed healthy controls and 15 right-handed patients with schizophrenia or schizoaffective disorder. Patients with schizophrenia were recruited at the Psychiatric Hospital of the University of Heidelberg. A structured clinical interview for DSM-IV, the MINI (Sheehan et al., 1998), was employed to confirm diagnoses and to rule out both other DSM Axis I disorders and current drug abuse. All patients were medicated with atypical antipsychotics (four clozapine, three
Demographic, clinical and behavioural data
Demographic, clinical and behavioural data are summarised in Table 1. There were no significant group differences with respect to age, education, reaction times, or the total amount of money earned. Patients with schizophrenia rated the reward cues and targets as more arousing than healthy controls (reward cues t = 2.5, p = 0.018, targets t = 2.1, p = 0.041) and displayed greater physical-anhedonia scores (t = 2.36, p = 0.013).
fMRI data
In order to identify significant activations in the contrasts of interest for
Discussion
We found that patients with schizophrenia treated with atypical antipsychotic drugs performed as well as healthy controls during the monetary incentive delay task. At the group level there were no significant differences between patients and controls in neural activation during anticipation or receipt of a reward. These observations correspond with most (Juckel et al., 2006a, Kirsch et al., 2007, Schlagenhauf et al., 2008) but not all previous studies (Waltz et al., 2008). More importantly and
Role of funding source
Joe J. Simon is supported by a doctoral scholarship from the state of Baden-Wuerttemberg through the Landesgraduiertenförderung (LGFG). The LGFG had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
Contributors
Joe Simon and Stefan Kaiser designed the study and wrote the protocol. Matthias Weisbrod and Daniela Roesch-Ely reviewed the protocol and contributed to the analytic approach. Joe Simon, Stephan Walther and Armin Biller collected the data. Joe Simon, Stephan Walther, Christoph Stippich and Armin Biller undertook the statistical analyses and prepared them for presentation. Joe Simon and Stefan Kaiser wrote the first draft of the manuscript. All authors contributed to and have approved the final
Conflict of interest
All authors declare that they have no conflicts of interest.
References (52)
- et al.
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Brain. Res. Brain. Res. Rev.
(1998) - et al.
Measuring emotion: the self-assessment manikin and the semantic differential
J. Behav. Ther. Exp. Psychiatry
(1994) Parametric analysis of fMRI data using linear systems methods
Neuroimage
(1997)- et al.
Anticipatory and consummatory components of the experience of pleasure: a scale development study
J. Res. Pers.
(2006) - et al.
Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure
Schizophr. Res.
(2007) - et al.
Psychomotor slowing, negative symptoms and dopamine receptor availability—an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients
Schizophr. Res.
(1998) - et al.
Dysfunction of ventral striatal reward prediction in schizophrenia
Neuroimage
(2006) Vulnerability to depression: a model centered on anhedonia
J. Affect. Disord.
(1996)- et al.
The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G)
J. Psychiatr. Res.
(1999) - et al.
Toward an objective characterization of an anhedonic phenotype: a signal-detection approach
Biol. Psychiatry
(2005)